LETTER
Synthesis of β-Amino Esters or Amides
1711
2004, 33, 599. (c) Jung, D.; Kim, Y. H. Synlett 2005, 3019.
(d) Concellón, J. M.; Rodríguez-Solla, H. Eur. J. Org.
Chem. 2006, 1613. (e) Kagan, H. B.; Gopalaiah, K. New J.
Chem. 2008, 32, 607. (f) Rudkin, I. M.; Miller, L. C.;
Procter, D. J. Organomet. Chem. 2008, 34, 19. (g) Nicolau,
K. C.; Ellery, S. P.; Chen, J. S. Angew. Chem. Int. Ed. 2009,
48, 7140. (h) Concellón, J. M.; Rodríguez-Solla, H.;
Concellón, C.; del Amo, V. Chem. Soc. Rev. 2010, 39, 4103.
(i) Procter, D. J.; Flowers, R. A. II.; Skrydstrup, T. Organic
Synthesis Using Samarium Diiodide: A Practical Guide;
Royal Society of Chemistry Publishing: Cambridge, 2010.
(j) Szostak, M.; Spain, M.; Parmar, D.; Procter, D. J. Chem.
Commun. 2012, 330. (k) Harb, H. Y.; Procter, D. J. Synlett
2012, 23, 6. (l) Szostak, M.; Spain, M.; Procter, D. J. Chem.
Soc. Rev. 2013, 42, 9155.
References and Notes
(1) For reviews on the synthesis of β-amino acids, see: (a) Cole,
D. C. Tetrahedron 1994, 50, 9517. (b) Enantioselective
Synthesis of β-Amino Acids; Juaristi, E., Ed.; Wiley-VCH:
New York, 1997. (c) Juaristi, E.; López-Ruiz, H. Curr. Med.
Chem. 1999, 6, 983. (d) Abele, S.; Seebach, D. Eur. J. Org.
Chem. 2000, 1. (e) Lui, M.; Sibi, M. Tetrahedron 2002, 58,
7991. (f) Davies, S. G.; Smith, A. D.; Price, P. D.
Tetrahedron: Asymmetry 2005, 16, 2833. (g) Sleebs, B. E.;
Van Nguyen, T. T.; Hughes, A. B. Org. Prep. Proced. Int.
2009, 41, 429. For recent papers on the synthesis of β-amino
acids, see: (h) Shen, B.; Johnston, J. N. Org. Lett. 2008, 10,
4397. (i) Yang, J. W.; Chandler, C.; Stadler, M.; Kampen,
D.; List, B. Nature (London, U.K.) 2008, 452, 453.
(j) Seayad, J.; Patra, P. K.; Zhang, Y.; Ying, J. Y. Org. Lett.
2008, 10, 953. (k) Lu, X.; Deng, L. Angew. Chem. Int. Ed.
2008, 47, 7710. (l) Martin, N. J. A.; Cheng, X.; List, B. J.
Am. Chem. Soc. 2008, 130, 13862. (m) Malkov, A. V.;
Stončius, S.; Vranková, K.; Arndt, M.; Kočovský, P. Chem.
Eur. J. 2008, 14, 8082. (n) Nolte, G. T.; Baxter, Vu. J. M.;
Leighton, J. L. Org. Lett. 2011, 13, 816. (o) Bea, S.-H.; Park,
H.-J.; Lee, S.-H.; Yun, H. Chem. Commun. 2011, 47, 5894.
(p) Wang, Q.; Leutzsch, M.; van Gemmeren, M.; List, B.
J. Am. Chem. Soc. 2013, 135, 15334.
(10) Corey, E. J.; Zheng, G. Z. Tetrahedron 1997, 12, 2045.
(11) (a) Hélion, F.; Namy, J.-L. J. Org. Chem. 1997, 64, 2944.
(b) Lannon, M.-I.; Hélion, F.; Namy, J.-L. Tetrahedron
2003, 59, 10551.
(12) Orsini, F.; Lucci, E. M. Tetrahedron Lett. 2005, 46, 1909.
(13) Nomura, R.; Matsuno, T.; Endo, T. J. Am. Chem. Soc. 1996,
118, 11666.
(14) Aspinall, H. C.; Greeves, N.; Valla, C. Org. Lett. 2005, 10,
1919.
(15) Hébri, H.; Dunach, E.; Heintz, M.; Troupel, M.; Périchon, J.
Synlett 1991, 901.
(16) Sun, L.; Sahloul, K.; Mellah, M. ACS Catal. 2013, 3, 2568.
(17) Concellón, J. M.; Rodríguez-Solla, H.; Concellón, C.; Díaz-
Pardo, A.; Llavona, R. Synlett 2011, 262.
(18) Wang, Y.; Song, J.; Hong, R.; Li, H.; Deng, L. J. Am. Chem.
Soc. 2006, 128, 8156.
(19) Procedure for the Synthesis of N-Tosyloctan-1-imine (1a)
A mixture of n-octanal (10 mmol), p-toluenesulfonamide
(10 mmol), sodium p-toluenesulfinate (10 mmol) in H2O (15
mL), and formic acid (15 mL) was stirred for 24 h at r.t. The
resulting white precipitate was collected by filtration,
washed with H2O (3 × 10 mL) and hexane (2 × 10 mL), then
dissolved in CH2Cl2 (100 mL), followed by addition of H2O
(35 mL) and sat. aq NaHCO3 (35 mL). The solution was well
stirred for 10 min at r.t. The organic phase was collected, the
aqueous phase was extracted with CH2Cl2 (3 × 70 mL).
The combined organic layers were dried over Na2SO4 and
concentrated in vacuo to yield N-tosyloctan-1-imine (1a) as
a colorless oil (1.84 g, 65%). This material was used without
further purification. 1H NMR (300 MHz, CDCl3): δ = 8.60 (t,
J = 4.6 Hz, 1 H), 7.81 (d, J = 8.2 Hz, 2 H), 7.34 (d, J = 8.2
Hz, 2 H), 2.51 (dt, J = 7.4, 4.6 Hz, 2 H), 2.40 (s, 3 H), 1.66–
1.57 (m, 2 H), 1.39–1.14 (m, 8 H), 0.86 (t, J = 6.8 Hz, 3 H).
13C NMR (75 MHz, CDCl3): δ = 178.4 (CH), 144.4 (C),
134.4 (C), 129.5 (2 × CH), 127.8 (2 × CH), 35.6 (CH2), 31.2
(CH2), 28.7 (CH2), 28.5 (CH2), 24.3 (CH2), 22.2 (CH2), 21.3
(CH3), 13.7 (CH3). IR (neat): ν = 3292, 1629, 1020, 737 cm–1.
(20) Please note that a minimum of 2.0 equiv of SmI2 are required
to carry out this transformation in a stoichiometric manner.
(21) Since magnesium is normally coated with a layer of MgO,
we have previously treated the magnesium turnings with a
few crystals of iodine to activate its surface.
(2) Sewald, N. Angew. Chem. Int. Ed. 2003, 42, 5794.
(3) β-Amino acids can be transformed into other compounds.
Piperidines: (a) Jefford, C. W.; Wang, J. B. Tetrahedron
Lett. 1993, 34, 2911. (b) Davis, F. A.; Santhanaraman, M.
J. Org. Chem. 2006, 71, 4222. (c) Davies, S. G.; Hughes, D.
G.; Price, P. D.; Roberts, P. M.; Russell, A. J.; Smith, A. D.;
Thomson, J. E.; Williams, O. M. H. Synlett 2010, 567.
Indolizidines: (d) Jefford, C. W.; Wang, J. B. Tetrahedron
Lett. 1993, 34, 3119. (e) Davis, F. A.; Yang, B. Org. Lett.
2003, 5, 5011. (f) Davis, F. A.; Yang, B. J. Am. Chem. Soc.
2005, 127, 8398. β-Lactams: (g) Juaristi, E.; Quintana, D.;
Escalante, J. Aldrichimica Acta 1994, 27, 3. (h) Tzouvelekis,
L. S.; Bonomo, R. A. Curr. Pharm. Des. 1999, 5, 847.
(i) Massova, I.; Mobashery, S. Curr. Pharm. Des. 1999, 5,
929. (j) Mascaretti, O. A.; Danelon, G. O.; Laborde, M.;
Mata, E. G.; Setti, E. L. Curr. Pharm. Des. 1999, 5, 939.
(k) Garau, G.; García-Sáez, I.; Bebrone, C.; Anne, C.;
Mercuri, P.; Galleen, M.; Frere, J. M.; Dideberg, O.
Antimicrob. Agents Chemother. 2004, 48, 2347. (l) Ozeki,
M.; Ochi, S.; Hayama, N.; Hosoi, S.; Kajimoto, T.; Node, M.
J. Org. Chem. 2010, 75, 4201.
(4) (a) Drey, C. N. C. In Chemistry and Biochemistry of the
Amino Acids; Barret, G. C., Ed.; Chapman and May: New
York, 1985, Chap. 3. (b) Griffith, O. W. Annu. Rev.
Biochem. 1986, 55, 855.
(5) (a) Tramontini, M.; Angiolini, L. In Mannich-Bases:
Chemistry and Uses; CRC: Boca Raton, FL, 1994.
(b) Cardillo, G.; Tomasini, C. Chem. Soc. Rev. 1996, 117.
(c) Enantioselective Synthesis of β-Amino Acids; Juaristi, E.;
Soloshonok, V. A., Eds.; Wiley-VCH: New York, 2005.
(6) For reviews on β-peptides, see: (a) Gellman, S. H. Acc.
Chem. Res. 1998, 31, 173. (b) Seebach, D.; Abele, S.;
Gademann, K.; Jaun, B. Angew. Chem. Int. Ed. 1999, 38,
1595.
(22) Procedure for the Synthesis of Ethyl 3-(Tosylamino)-
decanoate (3a)
(7) Krauthäuser, S.; Christianson, L. A.; Powell, D. R.;
Gellman, S. H. J. Am. Chem. Soc. 1997, 119, 11719.
(8) (a) Concellón, J. M.; Rodríguez-Solla, H.; Simal, C. Adv.
Synth. Catal. 2009, 351, 1238. (b) Concellón, J. M.;
Rodríguez-Solla, H.; Simal, C.; del Amo, V.; García-
Granda, S.; Díaz, M. R. Adv. Synth. Catal. 2009, 351, 2991.
(9) For recent reviews of SmI2, see: (a) Edmons, D. J.; Johnston,
D.; Procter, D. J. Chem. Rev. 2004, 104, 3371.
A solution of N-tosyloctan-1-imine (1a, 0.2 mmol) and ethyl
bromoacetate (2a, 0.2 mmol) in THF (2.5 mL) was added
dropwise at r.t. and vigorous stirring to a mixture of SmI2
(0.1 M in THF, 0.8 mL) and activated Mg (1.2 mmol) with
iodine and ZnCl2 (1.2 mmol) in THF (2.5 mL). After stirring
at the same temperature 3.5 h, the mixture was hydrolyzed
with an aq solution of HCl (0.1 M, 10 mL). The aqueous
phase was filtered through a pad of Celite® and extracted
(b) Concellón, J. M.; Rodríguez-Solla, H. Chem. Soc. Rev.
© Georg Thieme Verlag Stuttgart · New York
Synlett 2014, 25, 1709–1712